Patents by Inventor Louis Desantis, Jr.

Louis Desantis, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma
    Patent number: 5480900
    Abstract: Combinations of at least one clonidine derivative and at least one prostaglandin are used to treat glaucoma and ocular hypertension without some of the side effects typically associated with topical administration of prostaglandins.
    Type: Grant
    Filed: April 10, 1995
    Date of Patent: January 2, 1996
    Assignee: Alcon Laboratories, Inc.
    Inventors: Louis DeSantis, Jr., Verney L. Sallee
  • Topical ophthalmic compositions comprising 4-(3-substituted amino-2-hydroxypropoxy)-1,2,5-thiadiazoles and methods for their use
    Patent number: 5320839
    Abstract: Topical ophthalmic compositions comprising certain thiadiazoles are useful in the treatment of glaucoma and ocular hypertension. The thiadiazoles are slightly less potent than timolol; however, they have greatly reduced systemic side effects as compared to timolol.
    Type: Grant
    Filed: August 10, 1993
    Date of Patent: June 14, 1994
    Assignee: Alcon Laboratories, Inc.
    Inventors: Louis DeSantis, Jr., Robert J. Adamski
  • Use of certain sulfamoyl-substituted phenethylamine derivatives to reverse drug-induced mydriasis
    Patent number: 5288759
    Abstract: Certain sulfamoyl-substituted phenethylamine derivatives have been found to be useful in reversing or inhibiting drug-induced mydriasis. This application is especially useful in the area of diagnostics for eye examinations.
    Type: Grant
    Filed: August 27, 1992
    Date of Patent: February 22, 1994
    Assignee: Alcon Laboratories, Inc.
    Inventor: Louis DeSantis, Jr.
  • Anti-glaucoma compositions
    Patent number: 5182102
    Abstract: Ophthalmic pharmaceutical compositions useful in controlling elevated intraocular pressure associated with glaucoma and ocular hypertension are described. The compositions comprise a combination of a beta-blocker to reduce the production of aqueous humor and carbachol to enhance the outflow of aqueous humor. A method of controlling elevated intraocular pressure with those compositions is also described.
    Type: Grant
    Filed: July 12, 1991
    Date of Patent: January 26, 1993
    Assignee: Alcon Laboratories, Inc.
    Inventors: Louis DeSantis, Jr., Rajni Jani